IP Library Granted Patent US 8,154,285
Granted Patent B1
US 8,154,285 · App. 12/455,300 · Granted Apr 10, 2012

Non-external static magnetic field imaging systems, devices, methods, and compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,154,285
App. No.
12/455,300
Granted
Apr 10, 2012
Kind
B1
Abstract

Magnetic resonance systems, devices, methods, and compositions are provided. Further provided are systems, devices, methods, and compositions for obtaining magnetic resonance information of a region within a biological subject without the need or use of an external-magnet.

Claims (30)

1. A computer program product, comprising:

a non-transitory signal-bearing media containing computer instructions which, when run on a computing device, cause the computing device to implement a method including:

detecting a spatial distribution of a magnetic resonance event associated with a biological sample exposed to a surface-defined void of a ferromagnetic microstructure, the ferromagnetic microstructure configured to generate a static magnetic field within the surface-defined void and configured to affect a magnetic resonance relaxation process associated with the biological sample at least while the biological sample is received in the surface-defined void;

generating a response based on the detected spatial distribution of the magnetic resonance event; and

automatically communicating the response to a user.

2. The computer program product of claim 1 , wherein detecting the spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with tissue-contained nuclear magnetic resonance detectable nuclei exposed to the surface-defined void of the ferromagnetic microstructure.

3. The computer program product of claim 1 , wherein detecting the spatial distribution of the magnetic resonance event includes monitoring changes to at least one of a T 1 magnetic relaxation time or a T 2 magnetic relaxation time associated with tissue-contained nuclear magnetic resonance detectable nuclei exposed to the surface-defined void of the ferromagnetic microstructure.

4. The computer program product of claim 1 , wherein detecting the spatial distribution of the magnetic resonance event includes acquiring radio frequency information associated with regional changes in the magnetic resonance event generated by tissue-contained nuclear magnetic resonance detectable nuclei exposed to the surface-defined void of the ferromagnetic microstructure.

5. The computer program product of claim 1 , wherein detecting the spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with one or more nuclear magnetic resonance active nuclei exposed to the surface-defined void of the ferromagnetic microstructure.

6. The computer program product of claim 1 , wherein detecting the spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with one or more target spin species exposed to the surface-defined void of the ferromagnetic microstructure.

7. The computer program product of claim 1 , wherein detecting the spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with a targeted biological sample exposed to the surface-defined void of a selectively-targeted ferromagnetic microstructure.

8. The computer program product of claim 1 , wherein detecting the spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with a targeted biological sample exposed to a ferromagnetic microstructure having at least one selectively-accessible surface-defined void.

9. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one cell surface receptor targeting moiety.

10. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one transmembrane receptor targeting moiety.

11. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one antigen-targeting moiety.

12. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one immune-receptor targeting moiety.

13. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one folate receptor targeting moiety.

14. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one nucleotide binding moiety.

15. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one oligonucleotide binding moiety.

16. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one oligodeoxyribonucleotide binding moiety.

17. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one oligoribonucleotide binding moiety.

18. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one amyloid binding moiety.

19. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one β-amyloid binding moiety.

20. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including one or more genomic targets binding moiety.

21. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one oncogene binding moiety.

22. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one chromosome translocation binding moiety.

23. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one methylated deoxyribonucleic acid sequence binding moiety.

24. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one methylated deoxyribonucleic acid sequence including a methylated cytosine binding moiety.

25. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one methylated ribonucleic acid sequence binding moiety.

26. The computer program product of claim 1 , wherein detecting a spatial distribution of the magnetic resonance event includes detecting the spatial distribution of the magnetic resonance event associated with the ferromagnetic microstructure including at least one deoxyribonucleic acid sequence including unmethylated cytosine binding moiety.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2012
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 027758/0004 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2009
From: HYDE, RODERICK A.; KARE, JORDIN T.; KINDSVOGEL, WAYNE R.
To: SEARETE LLC
Reel/Frame 023212/0234 →